about
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancerN-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in ratsUrine protein analysis by gel electrophoresis and laser densitometry after chemotherapy in pediatric cancer patients.Oxazaphosphorines: new therapeutic strategies for an old class of drugs.Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivoDevelopment of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.Metabolism of ifosfamide during a 3 day infusion.Metabolism and transport of oxazaphosphorines and the clinical implications.The influence of ifosfamide scheduling on acute nephrotoxicity in childrenRisk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.Outcome and toxicity of an Ifosfamide-based soft tissue sarcoma treatment protocol in children. The importance of local therapy.Osteomalacia as a late metabolic complication of Ifosfamide chemotherapy in young adults: illustrative cases and review of the literature.Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumourUrological implications of cyclophosphamide and ifosfamide.Interleukin 18 as a marker of chronic nephropathy in children after anticancer treatment.Late effects of chemotherapeutic agents on renal function in childhood cancer survivors: a review of the literature.Nephrotoxicity of anticancer treatment.The effect of N-acetylcysteine on the antitumor activity of ifosfamide.Ifosfamide induced Fanconi syndrome.A novel alkylating agent, glufosfamide, enhances the activity of gemcitabine in vitro and in vivo.Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma.Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.Cisplatin dose rate as a risk factor for nephrotoxicity in children.Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model.Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child.Progressive glomerular toxicity of ifosfamide in children.Protective effects of alpha lipoic acid versus N-acetylcysteine on ifosfamide-induced nephrotoxicity.Novel Therapies for Acute Kidney Injury.Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance.
P2860
Q24197545-D7A8E7A8-1829-449C-B284-660451819F52Q24651059-6D142E43-E1C7-40AD-B93B-2B0FF217AF49Q30889898-E285F4E0-50C4-4DC4-BF93-241F917127E9Q34113899-40CF2BA8-A157-4307-B723-28BD05E2D615Q34749403-BE3E9070-9545-425F-A17D-B04A84364C0DQ35172556-786B3B2C-F90D-48A6-98A0-304BC0A04004Q35978501-4D528C6D-C4DF-41E9-8AA1-EC328E78F121Q36360811-95E6670A-FCD4-4697-BABE-68965CC0B61BQ36431761-EF658E57-165C-422D-A20C-803A272429C6Q36641763-F92F2E22-4241-4084-A858-AB65FEF447CBQ36673933-D7322EBF-D215-48CE-8050-CD155818B313Q36887175-E9143764-9095-42B2-BE23-433AF49DA0C7Q37193391-F21532D7-1926-484A-86DF-C3DD7B3B4455Q37264407-03D08760-B62D-4ED0-A69B-A050938C50AAQ37385625-A7CDF8C8-072C-4EF3-BBDD-02D4FCE2DE23Q38875402-13212FC4-D9A2-499C-AA03-29185F86FAF9Q39198933-D0440ACF-6F88-418D-97EE-B0D4A017AAA9Q39537262-805F2347-7D70-4D78-8D45-AD5580542D24Q39995377-2303AB15-06AF-4B81-A4AE-DD08F1CAD8C2Q40085159-2063C03A-D92F-46BB-9CEB-85F1575ECFB2Q40825202-97203FEF-89D7-4363-A3F7-74F8E7C768B4Q41677104-114D30C0-0314-47BF-B458-6CBEC1E051AAQ41736628-AC08D64C-7B35-4F95-AAA9-09BADF779E20Q41824829-2013CF79-7932-45DC-A3EF-1198F7BAAC81Q42412090-7154542A-0504-43B1-9BD3-3306663B0935Q42552096-758B1AF0-1554-4E3B-8A45-97429BCC38DFQ42555456-44953716-CE0C-46A7-9DDD-4893240E792EQ46607073-D46DFDBC-D148-444C-9010-A15D9798A6BCQ47099705-BE7B3CE4-DDB7-4813-BB3A-E012F9FDF8A7Q48244563-2F783C02-205E-4982-82C4-E7E72C385BB5
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Ifosfamide, mesna, and nephrotoxicity in children.
@ast
Ifosfamide, mesna, and nephrotoxicity in children.
@en
Ifosfamide, mesna, and nephrotoxicity in children.
@nl
type
label
Ifosfamide, mesna, and nephrotoxicity in children.
@ast
Ifosfamide, mesna, and nephrotoxicity in children.
@en
Ifosfamide, mesna, and nephrotoxicity in children.
@nl
prefLabel
Ifosfamide, mesna, and nephrotoxicity in children.
@ast
Ifosfamide, mesna, and nephrotoxicity in children.
@en
Ifosfamide, mesna, and nephrotoxicity in children.
@nl
P2093
P1476
Ifosfamide, mesna, and nephrotoxicity in children.
@en
P2093
A D Pearson
I M Sharkey
P304
P356
10.1200/JCO.1993.11.1.173
P407
P577
1993-01-01T00:00:00Z